Pediatric COVID-19 hospitalization trends by race and ethnicity, 2020-2023
Peer-Reviewed Publication
Updates every hour. Last Updated: 9-Jan-2026 09:11 ET (9-Jan-2026 14:11 GMT/UTC)
Researchers have developed an open-source molecular diagnostic assay for pathogen detection, successfully tested for COVID-19. The innovative RT-LAMP method is heat-stable, uses only non-proprietary reagents, and eliminates the need for expensive commercial kits and cold chain storage. Demonstrating performance in both Vienna and Ghana, the low-cost solution has potential for enhancing quick and equitable testing capabilities in resource-limited areas worldwide.
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform developed for COVID-19 vaccines to create the world’s first mRNA-based vaccine against a deadly, antibiotic-resistant bacterium. In this groundbreaking study, the researchers tested the vaccine’s resistance to the virulent pathogen that causes the disease and were able to demonstrate 100% protection against infection in animal models. The researchers now hope that this technology can be used to combat other lethal bacteria as well.